AI Dental X-Ray Software: The ROI Math on Pearl, Overjet & Computer-Vision Diagnostics
Here is the number that should keep you up at night: nearly half of the cavities in your patients’ mouths right now are invisible to you. On the Bulletproof Dental Practice Podcast, the founder of Pearl AI dropped a stat that landed like a punch — roughly 49% of caries and 42% of periapical lesions go undiagnosed, and about 22% of the caries dentists do flag turn out not to be carious at all. That is not a marketing slide. That is the gap between what’s actually happening on your radiographs and what your tired eyes catch on the 22nd bitewing of the day.
AI dental x-ray software — Pearl AI, Overjet, and the platforms racing behind them — exists to close that gap. But most dentists ask the wrong question. They ask, “Does the AI work?” The question that decides whether you buy is: does it make you money, and does it make you better? Let’s run the math the way Pete runs it and the way Craig frames it for the patient in the chair.
Why do so many diagnoses fall through the cracks?
It isn’t incompetence. It’s variance. Pearl ran an independent study — 136 practitioners handed the same full-mouth series and asked to diagnose and treatment plan it. The recommended treatment ranged from $300 to $36,000 on the identical films. On certain teeth, detection of recurrent decay was essentially a coin flip. This echoed a famous 1997 study where 50 dentists across 50 states produced wildly different plans on one patient.
Pete’s take on the podcast was blunt: this is a bottleneck problem, not a talent problem. You’re reading films at the end of a 30-patient day, between hygiene checks, with a schedule breathing down your neck. Computer vision doesn’t get tired. It doesn’t have a wedding-in-two-weeks patient in room 3 pulling its attention. It looks at every film the same way, every time. That consistency is the entire point — a permanent second set of eyes that never has a bad afternoon.
What does AI x-ray software actually cost — and what’s the ROI?
Pricing is refreshingly simple, and it’s where the ROI conversation gets loud. Based on what was laid out on the show, the tiers break down like this:
- Chairside diagnostic support (standalone): ~$299/month. The AI overlays detected pathology on the radiograph in real time and gives you a side-by-side second opinion to show the patient.
- Full integration (native): ~$600/month. Now the AI correlates imaging data with your practice management system — surfacing undiagnosed treatment across your entire patient population, feeding AI-driven morning huddles and call sheets.
Here’s the part that reframes it from “software expense” to “revenue engine.” When the platform scans your whole database, it doesn’t just help with today’s patient — it surfaces the undiagnosed opportunity sitting in files you already own. On day one, practices routinely see hundreds of thousands to millions of dollars in restorative, endo, and infection treatment that was diagnosed-but-never-scheduled or never diagnosed at all. At $300–$600/month, you need to find and complete a single crown or two to pay for the year. The rest is margin.
And the case acceptance lift is real: Pearl’s own case studies show a 30%+ increase in treatment acceptance. Not because the AI is a better salesperson — because the patient sees what you see. When decay is outlined in color on a screen the patient is looking at, the conversation stops being “trust me” and becomes “look at this.” That is a fundamentally different close.
Is it clinically legit, or just a gadget?
Fair skepticism — dentistry is a graveyard of overhyped gadgets. But the regulatory bar here is real: the leading platforms hold FDA clearances for identifying disease on 2D radiographs and have regulatory clearance in well over 100 countries. This is not a beta toy; it’s cleared diagnostic assistance being deployed at scale, and the trajectory is that AI radiographic support becomes a standard of care, not a differentiator. As Pearl’s founder put it, this capability is “an inevitability in all of medical radiology — it’s just too effective not to use.”
Translation for the owner thinking three years out: the question isn’t if you adopt AI diagnostics. It’s whether you adopt it while it’s still an edge, or after it’s table stakes and you’ve left five years of undiagnosed production on the table.
How do you roll it out without a team revolt?
This is where Craig’s voice matters more than Pete’s spreadsheet. Technology fails in practices not because the tech is bad, but because the humans feel replaced. The dentists who win with AI x-ray software frame it to the team the exact opposite way: this makes us better, and it protects our patients.
Craig’s framing on the show is the tell — the intraoral scanner “weather map,” the before-and-after that makes a 29-year-old grinder finally say “I better do something.” AI on the radiograph does the same emotional work: it externalizes the diagnosis so the patient owns it. Your job shifts from convincing to guiding. That’s not a threat to the clinician — that’s the clinician finally getting to be the trusted advisor instead of the salesperson.
A sane rollout looks like this:
- Weeks 1–2: Run it silently alongside your own reads. Calibrate trust. See where it catches what you missed and where you override it.
- Weeks 3–4: Turn on patient-facing overlays for new-patient exams and recare. Train the team to say “let me show you” instead of “you need.”
- Month 2: If you went native, run your first population-level review. Build call sheets off the undiagnosed funnel. Watch the schedule fill from patients you already had.
- Ongoing: Track case acceptance before and after. If you’re not seeing a double-digit lift, your bottleneck was never the diagnosis — it was the conversation, and that’s a coaching problem, not a software problem.
What’s the real risk of waiting?
Pete’s parting line on that episode is the whole strategy in one sentence: “Look for the bottleneck in your business. Technology will provide a solution — as long as you have your head up and not down.” AI x-ray software is the clearest bottleneck-killer available to a general practice right now: it attacks diagnostic variance, case acceptance, and undiagnosed production simultaneously, for the price of one crown a year.
The practices that treat it as an expense will keep leaving half their diagnoses invisible. The 1% will treat it as leverage — and use the recovered production to buy back their time, not just their overhead.
This is exactly the kind of edge we pressure-test on the Bulletproof Dental Practice Podcast — real tools, real numbers, no hype. It’s the same reason growth-minded owners come off the sidelines and into the room at the Bulletproof Summit, and why the ones serious about scaling join the Bulletproof Mastermind to implement it with people who’ve already done it.
Dentistry is a lonely profession. It doesn’t have to be. Adopt the technology, keep your independence, and build a practice — and a life — on your terms. Because Bulletproof is built for the 1% of dentists, who want 100% from life.
Blog
1+1=3 The Power Of Alignment and Delegation For You and Your OM with Erika Pusillo
, October 31, 2024
Look at These 3 Stats if You’re Thinking of Going Out of Network with Teresa Duncan
, January 11, 2023
Knowing What You Don’t Want with Judy Kay Mausolf of Culture Camp and Erika Pusillo
, November 30, 2022
Cabo This Week, Immersion Learning, Biggest Breakthroughs, Your Personal KPI is Net Worth
, November 2, 2022
Business is not Productivity, Productivity is not Profitability with Chris Salierno
, September 22, 2021
3 Biggest Bottlenecks of an Entrepreneurial Dentist: PART 2 with Perrin DesPortes of TUSK Partners


















































































































































































































